An open-label study evaluating the safety, behavioral, and electrophysiological outcomes of low-dose ketamine in children with ADNP syndrome

Alexander Kolevzon, Tess Levy, Sarah Barkley, Sandra Bedrosian-Sermone, Matthew Davis, Jennifer Foss-Feig, Danielle Halpern, Katherine Keller, Ana Kostic, Christina Layton, Rebecca Lee, Bonnie Lerman, Matthew Might, Sven Sandin, Paige M. Siper, Laura G. Sloofman, Hannah Walker, Jessica Zweifach, Joseph D. Buxbaum

Open source

DOI: 10.1016/j.xhgg.2022.100138
Published: 2022-10
Container: Human Genetics and Genomics Advances
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.xhgg.2022.100138,
  title = {An open-label study evaluating the safety, behavioral, and electrophysiological outcomes of low-dose ketamine in children with ADNP syndrome},
  author = {Alexander Kolevzon and Tess Levy and Sarah Barkley and Sandra Bedrosian-Sermone and Matthew Davis and Jennifer Foss-Feig and Danielle Halpern and Katherine Keller and Ana Kostic and Christina Layton and Rebecca Lee and Bonnie Lerman and Matthew Might and Sven Sandin and Paige M. Siper and Laura G. Sloofman and Hannah Walker and Jessica Zweifach and Joseph D. Buxbaum},
  year = {2022},
  journal = {Human Genetics and Genomics Advances},
  doi = {10.1016/j.xhgg.2022.100138},
  url = {https://doi.org/10.1016/j.xhgg.2022.100138}
}

RIS

TY  - JOUR
TI  - An open-label study evaluating the safety, behavioral, and electrophysiological outcomes of low-dose ketamine in children with ADNP syndrome
AU  - Alexander Kolevzon
AU  - Tess Levy
AU  - Sarah Barkley
AU  - Sandra Bedrosian-Sermone
AU  - Matthew Davis
AU  - Jennifer Foss-Feig
AU  - Danielle Halpern
AU  - Katherine Keller
AU  - Ana Kostic
AU  - Christina Layton
AU  - Rebecca Lee
AU  - Bonnie Lerman
AU  - Matthew Might
AU  - Sven Sandin
AU  - Paige M. Siper
AU  - Laura G. Sloofman
AU  - Hannah Walker
AU  - Jessica Zweifach
AU  - Joseph D. Buxbaum
PY  - 2022
JO  - Human Genetics and Genomics Advances
DO  - 10.1016/j.xhgg.2022.100138
UR  - https://doi.org/10.1016/j.xhgg.2022.100138
ER  -

APA

Kolevzon, A., Levy, T., Barkley, S., Bedrosian-Sermone, S., Davis, M., Foss-Feig, J., Halpern, D., Keller, K., Kostic, A., Layton, C., Lee, R., Lerman, B., Might, M., Sandin, S., Siper, P. M., Sloofman, L. G., Walker, H., Zweifach, J., & Buxbaum, J. D. (2022). An open-label study evaluating the safety, behavioral, and electrophysiological outcomes of low-dose ketamine in children with ADNP syndrome. Human Genetics and Genomics Advances. https://doi.org/10.1016/j.xhgg.2022.100138

Source records

crossref · retrieved 2026-09-26T03:29:48.965Z